Skip to main content

Animations

MJFF Publications

3931 - 3940 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2012
  • 2024
  • 2017
  • 2018
  • 2017
  • 2015
  • 2016
  • 2020
  • Summary Details
    OPEN
    Title: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212714
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?
    Journal Name: Current Neuropharmacology
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2174/1570159x21666230801140648
    Citation Count: 1
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 151
  • Summary Details
    OPEN
    Title: Characterizing enteric neurons in dopamine transporter (DAT)‐Cre reporter mice reveals dopaminergic subtypes with dual‐transmitter content
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16307
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease
    Journal Name: Clinical Nuclear Medicine
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/rlu.0000000000001885
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Progression of regional grey matter atrophy in multiple sclerosis
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awy088
    Citation Count: 331
  • Summary Details
    OPEN
    Title: Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awx285
    Citation Count: 413
  • Summary Details
    OPEN
    Title: Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awv202
    Citation Count: 84
  • Summary Details
    OPEN
    Title: Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease
    Journal Name: Antioxidants & Redox Signaling
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1089/ars.2015.6598
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Partial Correlation Coefficient for a Study With Repeated Measurements
    Journal Name: Statistics in Biopharmaceutical Research
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/19466315.2020.1784780
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.